Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Rikke Søgaard; Barbara Malene B Fischer; Jann Mortensen; Liselotte Højgaard; Ulrik Lassen

doi:10.1007/s00259-010-1703-y

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Rikke Søgaard, Barbara Malene B Fischer, Jann Mortensen, Liselotte Højgaard, Ulrik Lassen

42 Citations (Scopus)

Abstract

Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.

Original language	English
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	38
Issue number	5
Pages (from-to)	802-9
Number of pages	8
ISSN	1619-7070
DOIs	https://doi.org/10.1007/s00259-010-1703-y
Publication status	Published - 2011

Keywords

Adolescent
Adult
Aged
Aged, 80 and over
Cost-Benefit Analysis
Female
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Positron-Emission Tomography
Preoperative Period
Sensitivity and Specificity
Tomography, X-Ray Computed
Young Adult

Access to Document

10.1007/s00259-010-1703-y

Cite this

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. / Søgaard, Rikke; Fischer, Barbara Malene B; Mortensen, Jann et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, No. 5, 2011, p. 802-9.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{084b4c67f1b246f19e6186f957b1bca7,

title = "Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial",

abstract = "Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.",

keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Positron-Emission Tomography, Preoperative Period, Sensitivity and Specificity, Tomography, X-Ray Computed, Young Adult",

author = "Rikke S{\o}gaard and Fischer, {Barbara Malene B} and Jann Mortensen and Liselotte H{\o}jgaard and Ulrik Lassen",

year = "2011",

doi = "10.1007/s00259-010-1703-y",

language = "English",

volume = "38",

pages = "802--9",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

AU - Søgaard, Rikke

AU - Fischer, Barbara Malene B

AU - Mortensen, Jann

AU - Højgaard, Liselotte

AU - Lassen, Ulrik

PY - 2011

Y1 - 2011

N2 - Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.

AB - Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Cost-Benefit Analysis

KW - Female

KW - Humans

KW - Lung Neoplasms

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Positron-Emission Tomography

KW - Preoperative Period

KW - Sensitivity and Specificity

KW - Tomography, X-Ray Computed

KW - Young Adult

U2 - 10.1007/s00259-010-1703-y

DO - 10.1007/s00259-010-1703-y

M3 - Journal article

C2 - 21210111

SN - 1619-7070

VL - 38

SP - 802

EP - 809

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 5

ER -

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

Abstract

Keywords

Access to Document

Fingerprint

Cite this